XML 67 R56.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Beginning balance, $ 515 $ (1,726) $ (447) $ (2,604)
Realized and unrealized gains (losses):        
Included in regulatory assets 0 294 0 1,172
Included in regulatory liability (318) 0 642 0
Included in earnings [1] (665) (1,330) (1,262) (3,855)
Settlements 665 1,330 1,264 3,855
Ending balance, $ 197 $ (1,432) $ 197 $ (1,432)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.